Literature DB >> 33164164

Predicting topical drug clearance from the skin.

Maria Alice Maciel Tabosa1, Magdalena Hoppel2, Annette L Bunge3, Richard H Guy2, M Begoña Delgado-Charro2.   

Abstract

For topical drug products that target sites of action in the viable epidermal and/or upper dermal compartment of the skin, the local concentration profiles have proven difficult to quantify because drug clearance from the viable cutaneous tissue is not well characterised. Without such knowledge, of course, it is difficult-if not impossible-to predict a priori whether and over what time frame a topical formulation will permit an effective concentration of drug within the skin 'compartment' to be achieved. Here, we test the hypothesis that valuable information about drug disposition, and specifically its clearance, in this experimentally difficult-to-access compartment (at least, in vivo) can be derived from available systemic pharmacokinetic data for drugs administered via transdermal delivery systems. A multiple regression analysis was undertaken to determine the best-fit empirical correlation relating clearance from the skin to known or easily calculable drug properties. It was possible, in this way, to demonstrate a clear relationship between drug clearance from the skin and key physical chemical properties of the drug (molecular weight, log P and topological polar surface area). It was further demonstrated that values predicted by the model correlated well with those derived from in vitro skin experiments.

Entities:  

Keywords:  Dermato-pharmacokinetics; Drug disposition; Skin; Skin clearance; Transdermal patch

Mesh:

Year:  2020        PMID: 33164164      PMCID: PMC7987642          DOI: 10.1007/s13346-020-00864-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  32 in total

1.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration.

Authors:  D E Clark
Journal:  J Pharm Sci       Date:  1999-08       Impact factor: 3.534

Review 2.  Pharmacokinetic models of dermal absorption.

Authors:  K D McCarley; A L Bunge
Journal:  J Pharm Sci       Date:  2001-11       Impact factor: 3.534

Review 3.  Mathematical models of skin permeability: an overview.

Authors:  Samir Mitragotri; Yuri G Anissimov; Annette L Bunge; H Frederick Frasch; Richard H Guy; Jonathan Hadgraft; Gerald B Kasting; Majella E Lane; Michael S Roberts
Journal:  Int J Pharm       Date:  2011-02-25       Impact factor: 5.875

4.  Polar molecular surface properties predict the intestinal absorption of drugs in humans.

Authors:  K Palm; P Stenberg; K Luthman; P Artursson
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

5.  Drug interaction and location in liposomes: correlation with polar surface areas.

Authors:  G M M El Maghraby; A C Williams; B W Barry
Journal:  Int J Pharm       Date:  2005-01-20       Impact factor: 5.875

6.  Pharmacokinetics and metabolism of N-(2-hydroxyethyl)-2,5-[14C]-pyrrolidine (HEP, Epolamine) in male healthy volunteers.

Authors:  C Giachetti; A Assandri; G Mautone; E Tajana; B Palumbo; R Palumbo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

7.  QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents.

Authors:  E J Lien; H Gao
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

8.  Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.

Authors:  Marina Braun; Willi Cawello; Hilmar Boekens; Rolf Horstmann
Journal:  Br J Clin Pharmacol       Date:  2008-12-16       Impact factor: 4.335

9.  Species differences in percutaneous absorption of nicorandil.

Authors:  K Sato; K Sugibayashi; Y Morimoto
Journal:  J Pharm Sci       Date:  1991-02       Impact factor: 3.534

10.  Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.

Authors:  Leila Bastos Leal; Sarah F Cordery; M Begoña Delgado-Charro; Annette L Bunge; Richard H Guy
Journal:  Pharm Res       Date:  2017-01-17       Impact factor: 4.200

View more
  3 in total

Review 1.  The Expanded Role of Chitosan in Localized Antimicrobial Therapy.

Authors:  Lisa Myrseth Hemmingsen; Nataša Škalko-Basnet; May Wenche Jøraholmen
Journal:  Mar Drugs       Date:  2021-12-08       Impact factor: 5.118

2.  Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling.

Authors:  Andrea Pensado; Anita McGrogan; K A Jane White; Annette L Bunge; Richard H Guy; M Begoña Delgado-Charro
Journal:  Drug Deliv Transl Res       Date:  2021-10-01       Impact factor: 4.617

Review 3.  Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery.

Authors:  Jaskaran Bains; Scott Carver; Susan Hua
Journal:  Front Vet Sci       Date:  2022-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.